Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.46 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | STAT6 | P42226 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4615726 | 1.00 | CYP3A4 (0.46) | CYP3A4ALDH1A1LMNATP53NLRP3 | |
| SCHEMBL16268553 | 1.00 | CYP3A4 (0.46) | CYP3A4ALDH1A1LMNATP53NLRP3 | |
| SCHEMBL272274 | 1.00 | CYP3A4 (0.46) | CYP3A4ALDH1A1LMNATP53NLRP3 | |
| SCHEMBL3676278 | 0.96 | CYP3A4 (0.48) | CYP3A4ALDH1A1LMNATP53NLRP3 | |
| SCHEMBL3676277 | 0.96 | CYP3A4 (0.48) | CYP3A4ALDH1A1LMNATP53NLRP3 | |
| SCHEMBL23234194 | 0.89 | CYP3A4 (0.43) | CYP3A4ALDH1A1LMNATP53NLRP3 | |
| SCHEMBL9630691 | 0.88 | CYP3A4 (0.44) | CYP3A4ALDH1A1LMNATP53NLRP3 | |
| SCHEMBL9630684 | 0.88 | CYP3A4 (0.44) | CYP3A4ALDH1A1LMNATP53NLRP3 | |
| SCHEMBL21802956 | 0.88 | CYP3A4 (0.44) | CYP3A4ALDH1A1LMNATP53NLRP3 | |
| SCHEMBL9630687 | 0.88 | CYP3A4 (0.44) | CYP3A4ALDH1A1LMNATP53NLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 754 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | claimed |
| US-20230151305-A1 | FRAGRANCE COMPOSITION | SA, GIVAUDAN (CH) | 2023-05-18 | — | — | US | claimed |
| EP-4146778-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2023-03-15 | — | — | EP | claimed |
| WO-2021224201-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2021-11-11 | — | — | WO | claimed |
| EP-3897865-A1 | FRAGRANCE COMPOSITIONS | Firmenich SA (CH) | 2021-10-27 | — | — | EP | claimed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049395-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | KAO CORPORATION (JP) | 2010-09-30 | — | — | US | claimed |
| EP-2192178-A1 | B-GLUCURONIDASE INHIBITOR | Kao Corporation (JP) | 2010-06-02 | — | — | EP | claimed |
| WO-1998056337-A1 | MALODOR REDUCING COMPOSITION CONTAINING AMBER AND MUSK MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | CYP3A4 212/4885ALDH1A1 205/4885LMNA 1900/4885 |
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | GUSB, GAA, GANAB | CYP3A4 318/4885ALDH1A1 28/4885LMNA 3810/4885 |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | CYP3A4 388/4885ALDH1A1 413/4885LMNA 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.